These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31631163)

  • 21. Impact of bevacizumab chemotherapy on craniotomy wound healing.
    Clark AJ; Butowski NA; Chang SM; Prados MD; Clarke J; Polley MY; Sughrue ME; McDermott MW; Parsa AT; Berger MS; Aghi MK
    J Neurosurg; 2011 Jun; 114(6):1609-16. PubMed ID: 21142749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
    von Minckwitz G; Puglisi F; Cortes J; Vrdoljak E; Marschner N; Zielinski C; Villanueva C; Romieu G; Lang I; Ciruelos E; De Laurentiis M; Veyret C; de Ducla S; Freudensprung U; Srock S; Gligorov J
    Lancet Oncol; 2014 Oct; 15(11):1269-78. PubMed ID: 25273342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vacuum with mesh is a feasible temporary closure device after fascial dehiscence.
    Bjørsum-Meyer T; Skarbye M; Jensen KH
    Dan Med J; 2013 Nov; 60(11):A4719. PubMed ID: 24192239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative pressure wound therapy for at-risk surgical closures in patients with multiple comorbidities: a prospective randomized controlled study.
    Masden D; Goldstein J; Endara M; Xu K; Steinberg J; Attinger C
    Ann Surg; 2012 Jun; 255(6):1043-7. PubMed ID: 22549748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful management of abdominal wound dehiscence using a vacuum assisted closure system combined with mesh-mediated medial traction.
    Lord AC; Hompes R; Venkatasubramaniam A; Arnold S
    Ann R Coll Surg Engl; 2015 Jan; 97(1):e3-5. PubMed ID: 25519257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resection of the Right External Iliac Artery and Vein after Local Recurrence of Cecal Cancer].
    Yoshikawa T; Murai S; Kunugi C; Oto I; Kitasato K; Shimizu H; Yabe N; Kitagawa Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2196-8. PubMed ID: 26805309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Oncological Post-surgical Wound Dehiscence with Autologous Skin Micrografts.
    Baglioni E; Trovato L; Marcarelli M; Frenello A; Bocchiotti MA
    Anticancer Res; 2016 Mar; 36(3):975-9. PubMed ID: 26976986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wound complications after bevacizumab treatment in patients operated on for ovarian cancer.
    Koskas M; Chereau E; Ballester M; Selle F; Rouzier R; Daraï E
    Anticancer Res; 2010 Nov; 30(11):4743-7. PubMed ID: 21115934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
    Nagasaka T; Mishima H; Sawaki A; Shimokawa M; Inukai M; Shinozaki K; Tanioka H; Nasu J; Nishina T; Hazama S; Okajima M; Yamaguchi Y
    BMJ Open; 2016 Jun; 6(6):e011454. PubMed ID: 27256093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative pressure wound therapy reduces incidence of postoperative wound infection and dehiscence after long-segment thoracolumbar spinal fusion: a single institutional experience.
    Adogwa O; Fatemi P; Perez E; Moreno J; Gazcon GC; Gokaslan ZL; Cheng J; Gottfried O; Bagley CA
    Spine J; 2014 Dec; 14(12):2911-7. PubMed ID: 24769401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A Case of Cecal Cancer with Liver and Lung Metastases That Maintained Long Stable Disease by TFTD and Bevacizumab Chemotherapy].
    Takeuchi M
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1657-1660. PubMed ID: 30449858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal Cavity Eventration Treated by Means of the "Open Abdomen" Technique Using the Negative Pressure Therapy System--Case Report and Literature Review.
    Trzeciak PW; Porzeżyńska J; Ptasińska K; Walczak DA
    Pol Przegl Chir; 2015 Nov; 87(11):592-7. PubMed ID: 26816408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Techniques in the Use of Negative Pressure Wound Therapy for Closure of Complex Neonatal Abdominal Wounds.
    Bayci A; Akay B
    J Wound Ostomy Continence Nurs; 2018; 45(5):468-471. PubMed ID: 30188395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative pressure wound therapy with instillation, a cost-effective treatment for abdominal mesh exposure.
    Deleyto E; García-Ruano A; González-López JR
    Hernia; 2018 Apr; 22(2):311-318. PubMed ID: 29086171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
    Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
    Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A Case That Was Complicated with Pulmonary Artery Thrombosis during Chemotherapy of the Regimen of CapeOX plus Bevacizumab against Recurrence of Colon Cancer].
    Hariu T; Nako Y; Furutani A; Yamasaki S; Kitade T; Wakasa M; Sonoyama T
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2330-2332. PubMed ID: 30692454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two Cases of Rectal Cancer Resected Curatively after Chemotherapy with CapeOX plus Bmab].
    Chiku T; Sano W; Hashiba T; Togawa Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1647-9. PubMed ID: 26805125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stomal mucocutaneous dehiscence as a complication of a dynamic wound closure system following laparostomy: a case report.
    Raber MH; Steenvoorde P; de Wit R
    Ostomy Wound Manage; 2011 Jan; 57(1):34-7. PubMed ID: 21252398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vacuum-assisted closure for complicated neonatal abdominal wounds.
    Lopez G; Clifton-Koeppel R; Emil S
    J Pediatr Surg; 2008 Dec; 43(12):2202-7. PubMed ID: 19040935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.